Pharming (PHAR) Current Leases (2019 - 2026)

Pharming (PHAR) has 8 years of Current Leases data on file, last reported at $11.8 million in Q2 2026.

• Quarterly Current Leases fell 56.91% year-over-year to $11.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $11.8 million (down 56.91% YoY) and the FY2025 annual result came in at $14.4 million, up 387.14% from the prior year.
• Current Leases fell to $11.8 million in Q2 2026, from $14.7 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $31.1 million in Q1 2023 to a low of $15227.0 in Q3 2022.
• A 5-year average of $19.0 million and a median of $22.2 million in 2022 frame the typical range for Current Leases.
• The widest YoY moves for Current Leases: up 231046.69% in 2022, down 99.92% in 2022.
• Tracing PHAR's Current Leases over 5 years: stood at $3.5 million in 2022, then increased by 4.36% to $3.6 million in 2023, then declined by 18.53% to $2.9 million in 2024, then surged by 387.14% to $14.4 million in 2025, then declined by 17.44% to $11.8 million in 2026.
• The last three Current Leases figures came in at $11.8 million (Q2 2026), $14.7 million (Q1 2026), and $14.4 million (Q4 2025), per Business Quant data.